Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy

The gastrointestinal system, often regarded as the 'second brain of humanity,' maintains a profound connection with the cerebral realm. Unlocking the intricate metabolic pathways of gut microorganisms is paramount in the treatment of cerebral ailments. This review primarily focuses on biom...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Gong, Zhijun Liu, Piaopiao Zhou, Jiahong Li, Yang-Bao Miao
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2023-12-01
Series:Nano TransMed
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2790676023000547
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846170029967540224
author Ying Gong
Zhijun Liu
Piaopiao Zhou
Jiahong Li
Yang-Bao Miao
author_facet Ying Gong
Zhijun Liu
Piaopiao Zhou
Jiahong Li
Yang-Bao Miao
author_sort Ying Gong
collection DOAJ
description The gastrointestinal system, often regarded as the 'second brain of humanity,' maintains a profound connection with the cerebral realm. Unlocking the intricate metabolic pathways of gut microorganisms is paramount in the treatment of cerebral ailments. This review primarily focuses on biomimetic precision nanocarriers, harnessing metabolites derived from the gut microbiota, to target brain disorders. Elaborating on the constituents, it illuminates the unique interplay between metabolites originating from the gut microbiota and the cerebral domain. Moreover, the review underscores the symbiotic relationship between nanocarriers fashioned from gut microbiota-derived metabolites and the augmentation of cerebral well-being. Offering a comprehensive outlook, this review sheds light on recent applications, challenges, and future prospects of nanocarriers rooted in metabolites derived from the gut microbiota across a spectrum of disease treatments. It presents an expansive perspective on the attributes of nanocarriers engineered from gut microbiota-derived metabolites, facilitating a deeper understanding of the intricate nexus between these metabolites and cerebral disorders.
format Article
id doaj-art-a211a3d9ffd04609aa45d02000958dd2
institution Kabale University
issn 2790-6760
language English
publishDate 2023-12-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Nano TransMed
spelling doaj-art-a211a3d9ffd04609aa45d02000958dd22024-11-12T05:22:07ZengKeAi Communications Co., Ltd.Nano TransMed2790-67602023-12-0124100020Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapyYing Gong0Zhijun Liu1Piaopiao Zhou2Jiahong Li3Yang-Bao Miao4School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610041, ChinaUrology Institute of Shenzhen University, The Third Affiliated Hospital of Shenzhen University, Shenzhen University, Shenzhen 518000, ChinaDepartment of Critical Care Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian 350108, ChinaSchool of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610041, China; Corresponding authors.Department of Haematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, School of Medicine of University of Electronic Science and Technology of China, No. 32, West Section 2, First Ring Road, Qingyang District, Chengdu 610000, China; Corresponding authors.The gastrointestinal system, often regarded as the 'second brain of humanity,' maintains a profound connection with the cerebral realm. Unlocking the intricate metabolic pathways of gut microorganisms is paramount in the treatment of cerebral ailments. This review primarily focuses on biomimetic precision nanocarriers, harnessing metabolites derived from the gut microbiota, to target brain disorders. Elaborating on the constituents, it illuminates the unique interplay between metabolites originating from the gut microbiota and the cerebral domain. Moreover, the review underscores the symbiotic relationship between nanocarriers fashioned from gut microbiota-derived metabolites and the augmentation of cerebral well-being. Offering a comprehensive outlook, this review sheds light on recent applications, challenges, and future prospects of nanocarriers rooted in metabolites derived from the gut microbiota across a spectrum of disease treatments. It presents an expansive perspective on the attributes of nanocarriers engineered from gut microbiota-derived metabolites, facilitating a deeper understanding of the intricate nexus between these metabolites and cerebral disorders.http://www.sciencedirect.com/science/article/pii/S2790676023000547NanocarrierMetabolitesGut to BrainVagus NerveImmune System
spellingShingle Ying Gong
Zhijun Liu
Piaopiao Zhou
Jiahong Li
Yang-Bao Miao
Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
Nano TransMed
Nanocarrier
Metabolites
Gut to Brain
Vagus Nerve
Immune System
title Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
title_full Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
title_fullStr Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
title_full_unstemmed Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
title_short Biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
title_sort biomimetic nanocarriers harnessing microbial metabolites usher the path for brain disease therapy
topic Nanocarrier
Metabolites
Gut to Brain
Vagus Nerve
Immune System
url http://www.sciencedirect.com/science/article/pii/S2790676023000547
work_keys_str_mv AT yinggong biomimeticnanocarriersharnessingmicrobialmetabolitesusherthepathforbraindiseasetherapy
AT zhijunliu biomimeticnanocarriersharnessingmicrobialmetabolitesusherthepathforbraindiseasetherapy
AT piaopiaozhou biomimeticnanocarriersharnessingmicrobialmetabolitesusherthepathforbraindiseasetherapy
AT jiahongli biomimeticnanocarriersharnessingmicrobialmetabolitesusherthepathforbraindiseasetherapy
AT yangbaomiao biomimeticnanocarriersharnessingmicrobialmetabolitesusherthepathforbraindiseasetherapy